ISCHEMIC STROKE OR HIGH-RISK TIA (ABCD² ≥ 4)

Clinical trials for ISCHEMIC STROKE OR HIGH-RISK TIA (ABCD² ≥ 4) explained in plain language.

Never miss a new study

Get alerted when new ISCHEMIC STROKE OR HIGH-RISK TIA (ABCD² ≥ 4) trials appear

Sign up with your email to follow new studies for ISCHEMIC STROKE OR HIGH-RISK TIA (ABCD² ≥ 4), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New drug aims to stop second strokes in High-Risk patients

Disease control Not yet recruiting

This study tests whether adding a new cholesterol-lowering drug called Tolecilimab to standard treatment helps prevent second strokes in people who recently had a stroke or mini-stroke. Researchers will enroll 242 patients in China who have high levels of a specific cholesterol m…

Matched conditions: ISCHEMIC STROKE OR HIGH-RISK TIA (ABCD² ≥ 4)

Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

ISCHEMIC STROKE OR HIGH-RISK TIA (ABCD² ≥ 4)

Get alerted when new ISCHEMIC STROKE OR HIGH-RISK TIA (ABCD² ≥ 4) trials appear

New drug aims to stop second strokes in High-Risk patients